Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Amylyx Pharmaceuticals
Biotech
Amylyx CEOs take hard lessons to rebuild the pipeline
Amylyx’s co-CEOs Josh Cohen and Justin Klee have already had to make the toughest decision of their careers. Next up, they're rebuilding the pipeline.
Annalee Armstrong
Jul 10, 2024 7:00am
Amylyx seeks to fill Relyvrio-sized hole with $35M GLP-1 buy
Jun 24, 2024 10:18am
Amylyx stock slips 6% after phase 2 rare disease data drop
Apr 10, 2024 2:48pm
Seelos' sugar therapy fails to improve ALS severity in ph. 2/3
Mar 19, 2024 10:00am
FDA promotes Bumpus to replace Woodcock—Chutes & Ladders
Dec 1, 2023 9:48am
BrainStorm asks for ALS approval 1 year after FDA spiked data
Aug 15, 2022 12:28pm
